Evotec completes Aptuit acquisition

By Melissa Fassbender

- Last updated on GMT

Evotec entered into a definitive agreement to acquire Aptuit on July 30, 2017. (Image: iStock/daizuoxin)
Evotec entered into a definitive agreement to acquire Aptuit on July 30, 2017. (Image: iStock/daizuoxin)

Related tags Completeness

Evotec has completed its previously announced acquisition of Aptuit and has updated its financial targets for the year.

As Outsourcing-Pharma.com reported​, the acquisition enables Evotec to provide its customers with “an even better and more complete translation process from the discovery stage to the clinical manufacturing​,” according to Dr. Werner Lanthaler, Evotec CEO.

"We are very happy that the closing was faster than originally expected. This now brings a one-stop-solution together for our partners from target to IND and high end-CMC,​" Lanthaler told us.

Evotec purchased Aptuit from the private equity firm Welsh, Carson, Anderson & Stowe for a total consideration of approximately $300m (€256m).

Guidance update

Following the transaction’s closing, Evotec has also updated its financial targets for 2017.

According to the company, total group revenues are expected to increase by more than 40% compared to 2016 at which time it was approximately $192.59m (€164.5m).

Additionally, adjusted group EBITDA is expected to improve from $42.38m (€36.2m) in 2016 by more than 50%. Group R&D expenses are expected to be approximately $23.41m (€20m).

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us

Products

View more

Webinars